ImmunityBio, Inc. is upgraded to Buy reflecting improving Anktiva data & potential label expansions in NMIBC and NSCLC. Read ...
KYOTO--Researchers at Kyoto University have identified a new approach to a type of colorectal cancer that is resistant to ...
The Immune Atlas identifies immune signatures in MM, enhancing outcome prediction and guiding personalized therapies by ...
Approval of ANKTIVA was granted for BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ, with ...
QUILT-3.055 is a basket trial evaluating nogapendekin alfa inbakicept across multiple solid tumor types. In the NSCLC cohort, ...
ANKTIVA® plus checkpoint inhibitor (CPI) therapy demonstrated statistically significant immune restoration across two ...
Indian Defence Review on MSN
Brain parasite hijacks immune cells and uses them to survive
A parasite known to hide inside the human brain has revealed a chilling ability: it can infect the immune system’s top ...
3don MSN
T cells gain superior memory through new reprogramming method, boosting cancer-fighting abilities
Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...
Scientists have uncovered a hidden battle between a widespread brain parasite and the immune cells tasked with destroying it. A parasite that can quietly persist in the human brain is capable of ...
Researchers have identified a new way to reprogram T cells, which are infection and tumor-fighting white blood cells, so that they have a superior memory, thereby making them more effective in killing ...
Cell cycle checkpoint-related genes (CCCRGs) are implicated in the development and progression of hepatocellular carcinoma ...
A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback